| Literature DB >> 27538831 |
Cen Jiang1, Qi Ni1, Danfeng Dong1, Lihua Zhang1, Zhen Li1, Yuan Tian1, Yibing Peng2.
Abstract
Azole resistance of Candida tropicalis has, in recent years, become a serious issue in hospitals; however, there is limited knowledge of the mechanisms underlying this resistance. We have previously demonstrated that ERG11 plays a vital role in azole resistance in C. tropicalis. Here, we describe the expression and sequence variation of UPC2, which encodes a transcription factor of ERG11. Quantitative real-time RT-PCR showed that 31 azole-resistant C. tropicalis strains significantly overexpressed UPC2. Those isolates resistant to all three azole antifungals upregulated UPC2 expression to a greater degree than those resistant to only fluconazole or itraconazole. The UPC2 promoter contains mutations -118T-G and -155G-A in azole-resistant strains of C. tropicalis. Meanwhile, the mutation G392E was also detected twice in UPC2 gene in azole-resistant C. tropicalis and was demonstrated to mediate azole antifungal susceptibility by using Saccharomyces cerevisiae as an expression host, particularly for fluconazole and itraconazole.Entities:
Keywords: Antifungal resistance; Azole; Candida tropicalis; UPC2
Mesh:
Substances:
Year: 2016 PMID: 27538831 DOI: 10.1007/s11046-016-0050-3
Source DB: PubMed Journal: Mycopathologia ISSN: 0301-486X Impact factor: 2.574